GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma A/S (OSTO:INIT) » Definitions » 3-Year FCF Growth Rate

Initiator Pharma A/S (OSTO:INIT) 3-Year FCF Growth Rate : -6.70% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma A/S 3-Year FCF Growth Rate?

Initiator Pharma A/S's Free Cash Flow per Share for the three months ended in Mar. 2024 was kr-0.20.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -6.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 8 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Initiator Pharma A/S was 31.70% per year. The lowest was -123.50% per year. And the median was -18.00% per year.


Competitive Comparison of Initiator Pharma A/S's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Initiator Pharma A/S's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Initiator Pharma A/S's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma A/S's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Initiator Pharma A/S's 3-Year FCF Growth Rate falls into.



Initiator Pharma A/S 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Initiator Pharma A/S  (OSTO:INIT) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Initiator Pharma A/S 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Initiator Pharma A/S's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Initiator Pharma A/S (OSTO:INIT) Business Description

Traded in Other Exchanges
N/A
Address
Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma A/S is a clinical Stage Life Science company engaged in the research and development of various drugs targeting medical needs within the central and peripheral nervous system. The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men. Its MRI drug candidates also include IPDP2015 for the treatment of depression; and IPNP2015 to treat neuropathic pain.

Initiator Pharma A/S (OSTO:INIT) Headlines

No Headlines